Boston Scientific BSX MedSurg — Net sales of reportable segments

Similar metrics at other companies

GLW

GLWTotal Reportable Segments — Segment net sales

$4.44B+20.1%

SOLVMedSurg — Total Net Sales

$1.37B+12.6%

SOLVMedSurg — Cost of Sales

$595M-1.3%

AOSReportable Segments — Net Sales

$945.6M-1.9%

MDTReportable segment net sales — Net Sales

$6.66B+8.5%

LOWReportable Segment — Net Sales

$21.32B+1.9%

FAQ

What is Boston Scientific's medsurg — net sales of reportable segments?

Boston Scientific (BSX) reported medsurg — net sales of reportable segments of $1.82B in Q2 2026.

How has Boston Scientific's medsurg — net sales of reportable segments changed year-over-year?

Boston Scientific's medsurg — net sales of reportable segments increased by 6.1% year-over-year, from $1.71B to $1.82B.

What is the long-term trend for Boston Scientific's medsurg — net sales of reportable segments?

Over 4 years (2021 to 2025), Boston Scientific's medsurg — net sales of reportable segments has grown at a 11.7% compound annual growth rate (CAGR), from $4.39B to $6.84B.

What does medsurg — net sales of reportable segments mean?

The total revenue generated by the MedSurg segment from the sale of medical devices and related services to external customers. This is a primary indicator of the segment's market demand and competitive success.